Research location
Vigo
Pontevedra, Spain
Advertisement
Research activity in Vigo
Pontevedra, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 109 trials and 133 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Vigo
109 linked trials · page 1 of 3Multicenter Prospective Observational Study on Prostate Salvage Using High-dose-rate Brachytherapy.NCT07860528 · 2026-03-11 · 1 site observation
RECRUITING
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)NCT07282574 · 2026-03-10 · 1 site observation
RECRUITING
Impact of a Perioperative Physical Exercise and Respiratory Physiotherapy Program on the Patient Undergoing Bariatric SurgeryNCT06987903 · 2025-05-07 · 1 site observation
RECRUITING
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.NCT06431633 · 2025-02-04 · 1 site observation
RECRUITING
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionNCT06736574 · 2024-12-19 · 1 site observation
RECRUITING
Pathological Response After Neoadjuvant Treatment on NSCLCNCT05167487 · 2021-12-13 · 1 site observation
RECRUITING
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast CancerNCT04889924 · 2021-06-11 · 2 site observations
RECRUITING
Efficacy and Safety Evaluation for the Treatment of Allergy Against MitesNCT04435990 · 2020-10-06 · 1 site observation
RECRUITING
Treatment of Hypertension During SleepNCT03457168 · 2019-02-01 · 5 site observations
RECRUITING
Usefulness of a Virtual Response Test as a Predictor of Functional and Cognitive Abilities in Older Adults With Different Degrees of Cognitive Impairment: a Pilot Study (ReactVR)NCT07620509 · 2026-05-25 · 1 site observation
COMPLETED
Immersive Physical Activity Program for Overweight SchoolchildrenNCT07681856 · 2026-01-20 · 1 site observation
ENROLLING_BY_INVITATION
Effectiveness of Home-Based Exercise and Brain Stimulation for Reducing Fatigue in Patients With Multiple SclerosisNCT07567989 · 2025-01-01 · 1 site observation
ENROLLING_BY_INVITATION
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With SurgeryNCT06161441 · 2024-07-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Nutritional Assessment of Patients With Non-small Cell Lung Cancer Treated With OsimertinibNCT07559526 · 2024-03-20 · 1 site observation
COMPLETED
Immersive Virtual Reality and Exercise Programs in Multiple SclerosisNCT07543900 · 2024-03-01 · 1 site observation
COMPLETED
A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical PracticeNCT06251986 · 2024-02-26 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)NCT06065748 · 2023-12-11 · 1 site observation
ACTIVE_NOT_RECRUITING
IMM60 and Pembrolizumab in Melanoma and NSCLCNCT05709821 · 2023-11-15 · 1 site observation
TERMINATED
A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.NCT05985915 · 2023-10-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)NCT06053775 · 2023-09-27 · 1 site observation
ACTIVE_NOT_RECRUITING
PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With EribulinNCT05810870 · 2023-05-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant NeratinibNCT05252988 · 2022-08-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's SyndromeNCT05349214 · 2022-08-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)NCT05153239 · 2022-07-22 · 1 site observation
COMPLETED
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)NCT05147220 · 2021-12-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)NCT04961996 · 2021-08-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to LamivudineNCT04880785 · 2021-07-28 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative TherapyNCT04873362 · 2021-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Locoregional Control With Radiotherapy of Breast Cancer Patients With MACrometastases Treated With MAstectomy (MACMA)NCT06378294 · 2021-04-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Mepolizumab on Severe Eosinophilic AsthmaNCT04641741 · 2021-04-01 · 1 site observation
UNKNOWN
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)NCT04586010 · 2021-03-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated PatientsNCT04512430 · 2020-12-02 · 1 site observation
TERMINATED
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)NCT04544436 · 2020-11-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple SclerosisNCT04544449 · 2020-10-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 1 site observation
COMPLETED
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer PatientsNCT04293393 · 2020-10-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of the Immunity of Patients With Lung Cancer and COVID-19 InfectionNCT04407143 · 2020-04-15 · 1 site observation
COMPLETED
A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast CancerNCT04148911 · 2019-12-10 · 1 site observation
COMPLETED
Monitoring of Mobility of Parkinson's Patients for Therapeutic Purposes - Clinical TrialNCT04176302 · 2019-11-26 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple SclerosisNCT04035005 · 2019-08-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's SyndromeNCT04035668 · 2019-07-12 · 1 site observation
TERMINATED
NADIM II: Neo-Adjuvant ImmunotherapyNCT03838159 · 2019-05-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Atezolizumab Plus Bevacizumab in First Line NSCLC PatientsNCT03836066 · 2019-05-15 · 1 site observation
COMPLETED
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT03778931 · 2019-05-10 · 1 site observation
COMPLETED
Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positiveNCT03790397 · 2019-02-26 · 1 site observation
COMPLETED
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerNCT03701334 · 2018-12-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple SclerosisNCT03593590 · 2018-11-12 · 1 site observation
COMPLETED
Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse RiskNCT03800355 · 2018-09-14 · 1 site observation
COMPLETED
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerNCT03498716 · 2018-08-02 · 1 site observation
TERMINATED
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)NCT03599245 · 2018-07-12 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.